The LDA offers a wide variety of resources, many free. Download and print free brochures, pie graphs and maps, order free handouts or low cost books, view and/or purchase scientific conference videos, access information on Lyme and kids and schools, apply for LymeAid 4 Kids funds for children without insurance for Lyme disease, read articles on disability and medical insurance, and view tick-borne diseases rash photos. Access the LDA’s Conflicts of Interest in Lyme Disease: Laboratory Testing, Vaccination, and Treatment Guidelines, written by author Pamela Weintraub for the LDA in 2001, years before her book, Cure Unknown Inside the Lyme Disease Epidemic, was published.
We are constantly trying to provide products and services to help raise awareness. Here are the top ten picks over time.
TickLES (Kids’ 14 min prevention video) and Play Tick Tackler Video Game
Order Free Brochures (limited to 200)
Other Tick-Borne Diseases (co-infections)
Dr. Referral (connect to Lyme-literate doctors nationally)
How A Tick Can Make You Sick (prevention PowerPoint geared to kids, schools & scouts)
Lyme Disease Case Maps (where & how much US Lyme)
Medical Photos (ticks, rashes and microscropic images)
How to Remove a Tick & Prevention
Public Service Announcements (free PSAs for your own use)
The CDC published, in the February edition of its “Emerging Infectious Diseases,” two new papers pertaining to Lyme disease case numbers. CDC indicates that the researchers found ~ 476,000 people are diagnosed with and treated for Lyme disease each year in the U.S. This is a 59% increase from their previous estimate of ~300,000. Also, CDC posted a new page to its website, Syndromic Surveillance of Emergency Department Visits for Tick Bites, showing tick bites by time, age/sex, and region.
About LymeAid 4 Kids (LA4K) – The Lyme Disease Association started LA4K fund in 2003 and has distributed monies for children all over the U.S.since 2004, Developed with the help of author Amy Tan, the fund is for children who do not have insurance coverage or receive reimbursement for Lyme disease treatment/diagnosis and whose families […]
On Thursday, December 17, 2020, Project Lyme will host a Zoom meeting with Robert Bransfield, MD and Pat Smith, President, Lyme Disease Association, discussing the IDSA, relationship to CDC, what are the new guidelines, how have they changed, comparison to ILADS guidelines and other topics.
In a retrospective review on the use of Disulfiram as a repurposed drug in the treatment of Lyme and Babesiosis, most patients experienced benefits with regard to their symptoms. It was found that although patients on high dose experienced higher risk for adverse reactions than the low dose patients, they were also more likely to […]
A review article has just been published by the Journal of Medical Entomology describing the ticks and tick-borne diseases of Colorado which includes tick-host associations, geographic distributions and medical/veterinary importance. In this article, 28 species of endemic ticks in Colorado are described as well as an additional 5 species that are occasionally detected, 13 exotic […]
A new direct test for Lyme disease was announced by Galaxy Diagnostics Inc., the Nanotrap® Urine Test for Lyme Borreliosis. This is a urine-based Lyme antigen test, that Galaxy states “provides the most sensitive direct detection of Borrelia burgdorferi infection at all stages of the disease.” The test is easily administered through collection of urine; and identifies positive cases […]
The Lyme Disease Association (LDA) is providing you with this updated November 2, 2020, COVID-19 protocol developed by the Chief of Pulmonary and Critical Care Medicine, EVMS. The EVMS Medical continually updates this guideline as new information emerges, primarily to provide new information to physicians. This information is provided by LDA for informational purposes […]
Richard Horwitz, MD, et al., have published a new case study and retrospective chart review of 40 patients on double dose dapsone combination therapy (DDD CT) in the journal Antibiotics.
The study found that of the 40 patients analyzed, an 8-week course of dapsone combined with doxycycline and rifampin effectively improved symptoms in 98% of patients, as well as led to long-term remission in 45% of the total patients studied, even though most of the individuals were ill for a decade or longer.
A study published in the journal Diagnostic Microbiology and Infectious Disease addresses the observed negative effects of the COVID-19 pandemic on the timely diagnosis of tick-borne infections (TBD) in three adult patients.
The Lyme Disease Association Inc. is providing you with information from the Centers for Disease Control & Prevention (CDC) on the U.S reported Lyme disease case numbers by county in each state for the years 2000-2018. 2000-2007 data reflect surveillance case definition at that time and reflect confirmed cases. 2008-present data reflect that surveillance case […]
